Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enanta Pharmaceuticals

7.09
+0.50007.59%
Post-market: 7.600.5100+7.19%18:43 EDT
Volume:216.73K
Turnover:1.50M
Market Cap:151.56M
PE:-1.56
High:7.11
Open:6.59
Low:6.44
Close:6.59
Loading ...
Aug 05, 2021

Major Issues Report

8-K - Current report
Jul 16, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2021

Major Issues Report

8-K - Current report
Mar 05, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 09, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Major Issues Report

8-K - Current report
Feb 05, 2021

Major Issues Report

8-K - Current report
Jan 28, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 04, 2020

Major Issues Report

8-K - Current report
Nov 25, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 23, 2020

Major Issues Report

8-K - Current report